-
Something wrong with this record ?
Apoferritin applications in nanomedicine
Z. Heger, S. Skalickova, O. Zitka, V. Adam, R. Kizek,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
ProQuest Central
from 2006-06-01 to 2021-01-31
Health & Medicine (ProQuest)
from 2006-06-01 to 2021-01-31
PubMed
25405799
DOI
10.2217/nnm.14.119
Knihovny.cz E-resources
- MeSH
- Apoferritins chemistry therapeutic use MeSH
- Biosensing Techniques MeSH
- Genetic Therapy MeSH
- Protein Conformation MeSH
- Humans MeSH
- Nanomedicine * MeSH
- Drug Carriers MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Nanomedicine as a continuously evolving discipline is still looking for a structure with perfect properties that is usable as a multifunctional transporter. Great potential is attributed to synthetic materials such as fullerenes, porous hollow silica nanoparticles and single-wall nanotubes, among others. However, materials that are natural to the human body are more acceptable by the organism, and thus become an attractive approach in this field of research. Ferritins are proteins that naturally occur in most living organisms throughout evolution and may be a possible transporter choice. Numerous applications have demonstrated the possibilities of iron-free ferritins, called apoferritins, serving as platforms for various nanomedical purposes This article summarizes the advantages and disadvantages of these proteins and discusses their practical applications and future perspectives.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031719
- 003
- CZ-PrNML
- 005
- 20151014100601.0
- 007
- ta
- 008
- 151005s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2217/nnm.14.119 $2 doi
- 035 __
- $a (PubMed)25405799
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Heger, Zbynek $u Department of Chemistry & Biochemistry, Faculty of Agronomy, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic.
- 245 10
- $a Apoferritin applications in nanomedicine / $c Z. Heger, S. Skalickova, O. Zitka, V. Adam, R. Kizek,
- 520 9_
- $a Nanomedicine as a continuously evolving discipline is still looking for a structure with perfect properties that is usable as a multifunctional transporter. Great potential is attributed to synthetic materials such as fullerenes, porous hollow silica nanoparticles and single-wall nanotubes, among others. However, materials that are natural to the human body are more acceptable by the organism, and thus become an attractive approach in this field of research. Ferritins are proteins that naturally occur in most living organisms throughout evolution and may be a possible transporter choice. Numerous applications have demonstrated the possibilities of iron-free ferritins, called apoferritins, serving as platforms for various nanomedical purposes This article summarizes the advantages and disadvantages of these proteins and discusses their practical applications and future perspectives.
- 650 _2
- $a apoferritiny $x chemie $x terapeutické užití $7 D001052
- 650 _2
- $a biosenzitivní techniky $7 D015374
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a genetická terapie $7 D015316
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nanomedicína $7 D050997
- 650 _2
- $a konformace proteinů $7 D011487
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Skalickova, Sylvie
- 700 1_
- $a Zitka, Ondrej
- 700 1_
- $a Adam, Vojtěch $7 xx0064599
- 700 1_
- $a Kizek, Rene
- 773 0_
- $w MED00186372 $t Nanomedicine (London, England) $x 1748-6963 $g Roč. 9, č. 14 (2014), s. 2233-45
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25405799 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151014100751 $b ABA008
- 999 __
- $a ok $b bmc $g 1092595 $s 914845
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 9 $c 14 $d 2233-45 $i 1748-6963 $m Nanomedicine $n Nanomedicine (Lond) $x MED00186372
- LZP __
- $a Pubmed-20151005